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The complexity of cell and tissue proteomes presents one of the most signiﬁcant technical challenges
in proteomic biomarker discovery. Multidimensional liquid chromatography-tandem mass spectrometry
(LC-MS/MS)-based shotgun proteomics can be coupled with selective enrichment of cysteinyl peptides
(Cys-peptides) to reduce sample complexity and increase proteome coverage. Here we evaluated the
impact of Cys-peptide enrichment on global proteomic inventories. We employed a new cleavable thiol-
reactive biotinylating probe, N-(2-(2-(2-(2-(3-(1-hydroxy-2-oxo-2-phenylethyl)phenoxy)acetamido)ethoxy)-
ethoxy)ethyl)-5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide (IBB), to capture Cys-
peptides after digestion. Treatment of tryptic digests with the IBB reagent followed by streptavidin
capture and mild alkaline hydrolysis releases a highly puriﬁed population of Cys-peptides with a residual
S-carboxymethyl tag. Isoelectric focusing (IEF) followed by LC-MS/MS of Cys-peptides signiﬁcantly
expanded proteome coverage in Saccharomyces cerevisiae (yeast) and in human colon carcinoma RKO
cells. IBB-based fractionation enhanced detection of Cys-proteins in direct proportion to their cysteine
content. The degree of enrichment typically was 2-8-fold but ranged up to almost 20-fold for a few
proteins. Published copy number annotation for the yeast proteome enabled benchmarking of MS/MS
spectral count data to yeast protein abundance and revealed selective enrichment of cysteine-rich,
lower abundance proteins. Spectral count data further established this relationship in RKO cells.
Enhanced detection of low abundance proteins was due to the chemoselectivity of Cys-peptide capture,
rather than simpliﬁcation of the peptide mixture through fractionation.
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Introduction
The tremendous range of protein concentrations in living
systems presents the greatest barrier to comprehensive pro-
teome analysis. Low abundance proteins are difﬁcult to detect
in the presence of much more abundant proteins, particularly
in shotgun proteome analyses using liquid chromatography-
tandem mass spectrometry (LC-MS/MS).
1 Multidimensional
protein and peptide separations are widely used to improve
depth of proteome analysis.
1 Another useful approach is
selective afﬁnity capture or chemoselective fractionation, which
samples peptide or protein subsets that share some common
chemical characteristic. Afﬁnity-based techniques have been
described to enrich peptides containing cysteine,
2-6 arginine,
7
histidine,
8 methionine,
9 as well as peptides that are phospho-
rylated
10,11 and glycosylated.
12,13 These studies all have dem-
onstrated that chemoselective fraction simpliﬁes complex
mixtures. Chemoselective fractionation also enhances detection
of lower abundance proteins in shotgun proteome analyses
3-6
and in targeted analyses.
14,15
Cys-peptides are attractive targets for chemoselective frac-
tionation. In silico analysis of the current IPI human protein
database (version 3.37) indicates that 91% of the indexed
proteins contain at least one cysteine residue and that 24% of
predicted tryptic peptides contain a cysteine. Similarly, for
Saccharomyces cerevisiae (yeast) proteins, 88% contain cysteine
and would yield 16% tryptic peptides (SGD orf_trans-all,
downloaded July 17, 2007). Thus, a substantial fraction of these
proteomes can be represented by a subset of tryptic peptides.
The unusual nucleophilicity and redox chemistries of the
cysteine thiol and thiolate anions provide high selectivity for
modiﬁcation by electrophilic reagents and thiol-disulﬁde
reagents.
One approach to Cys-peptide capture is via thiol-disulﬁde
chemistry using thiopropyl sepharose.
16 In this approach,
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Published on Web 08/23/2010proteins are reduced and digested without prior thiol alkylation
and the peptides then are captured on the resin. After removal
of noncovalently captured peptides, the Cys-peptides are
released with a reducing agent. A variation on the thiol-disulﬁde
capture strategy involves reversible modiﬁcation of cysteine
residues using Ellman’s reagent and further isolation of these
labeled Cys-peptides through combined fractional diagonal
chromatography.
17 More recently, p-hydroxymercuribenzoate
based agarose beads were also reported to enrich Cys-peptides
and further enhance the protein identiﬁcation through a
mercury sulfhydryl interaction.
18,19
Capture of cysteinyl peptides by covalent thiol alkylation with
a biotinylating reagent is the basis of the isotope coded afﬁnity
tag (ICAT) reagents,
2 which employ an iodoacetamido elec-
trophile that forms a stable thioether through SN2 substitution.
These reagents are used to label thiols in reduced, intact
proteins, which are then digested and the biotinylated Cys-
peptides are enriched by chromatography on immobilized
streptavidin. The ICAT reagents include stable isotope labels
for relative quantitation (i.e., light and heavy forms).
Recently, our research group has used biotin-tagged, thiol-
reactive electrophiles as model probes to study the covalent
modiﬁcation of proteins and the roles of protein alkylation in
chemical toxicity and stress signaling.
20-23 Through this work
we also became familiar with two drawbacks of biotin-avidin
capture. The minor drawback is that, for some labeled peptides,
fragmentation of the adduct tag in collision-induced dissocia-
tion complicates data analysis.
24 The second, more signiﬁcant
problem is the difﬁculty of recovering biotinylated peptides
from avidin columns under mild conditions. Complete release
of biotinylated peptides required extreme conditions (e.g.,
boiling SDS-PAGE loading buffer or acidic solvents), which
frequently results in release of streptavidin protein from the
resin. This problem had been addressed previously by the
developers of second-generation versions of ICAT reagents,
which incorporated a photocleavable linker
6 or an acid-
cleavable linker
25 to release Cys-peptides from streptavidin. The
latter is marketed as a “Cleavable ICAT” reagent (AB Sciex),
which is a proprietary compound that incorporates light and
heavy isotope tags, a biotin tag and the acid-cleavable linker
and is used for comparative quantitation.
The present study developed from our project funded by the
National Cancer Institute Clinical Proteomic Technology As-
sessment for Cancer (CPTAC) program, in which we proposed
to quantitatively evaluate Cys-peptide capture via a global
proteome analysis with current multidimensional LC-MS/MS
technology. We also had recently described a photocleavable
biotinyl linker for use in Click chemistry labeling of protein
adducts formed by alkynyl electrophile probes.
26 When we
adapted this chemistry to synthesize a photocleavable, thiol-
reactive biotinylating reagent, we learned that the linker was
susceptible to mild base cleavage, thus enabling recovery of
Cys-peptides under mild conditions compatible with our
proteomics workﬂow. Our purpose was not to introduce a new
reagent per se, but to characterize the impact of Cys-peptide
enrichment on a global proteomic scale. Here we describe
application of this reagent as a tool to characterize cysteine
peptidomes and proteomes by multidimensional LC-MS/MS.
We further employed a concentration-annotated yeast standard
proteome described in a recent CPTAC study
27 as a reference
material to assess the enrichment and detection of Cys-peptides
and proteins at known levels of abundance. Finally, we used
these data to validate a spectral counting approach to assess
the impact of Cys-peptide capture on proteomic inventory in
a human cell line proteome.
Experimental Procedures
Materials. Streptavidin Sepharose High Performance was
purchased from G.E. Healthcare Bioscience Corp (Pittsburgh,
PA). Trypsin Gold was purchased from Promega (Madison, WI).
The model Cys-containing peptide Ac-AVAGCAGAR (Ac-TpepC)
was purchased from New England peptide (Gardner, MA).
Synthesis of N-(2-(2-(2-(2-(3-(1-hydroxy-2-oxo-2-phenyleth-
yl)phenoxy)acetamido)ethoxy)-ethoxy)ethyl)-5-(2-oxohexahy-
dro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide (IBB) is de-
scribed in the Supporting Information. All other chemical
reagents were purchased from commercial sources and were
used without further puriﬁcation.
Model Peptide Studies. The cysteine containing peptide Ac-
AVAGCAGAR (Ac-TpepC) was used as model peptide for initial
studies if Cys-peptide capture. A sample of 40 nmol Ac-TpepC
was mixed with 800 nmol dithiothreitol in 16 uL of 100 µM
sodium phosphate, pH 7 for 5 min at room temperature. To
this solution was added 64 µL of the same buffer and 40 µL
IBB (200 mM in triﬂuoroethanol (TFE)) and the solution was
incubated in the dark for 20 min to form the S-alkyl-(IBB)-Ac-
TpepC conjugate. Aliquots (8 µL) were taken and diluted with
(a) 92 µL of 100 mM sodium phosphate buffer at either pH
5.5, 6.5, or 7.5 at 37 °C for 4 h; (b) with 92 µL of 50 mM sodium
acetate buffer, pH 4.5 at room temperature for 16 h; (c) with
92 µL of 50 mM ammonium bicarbonate, pH 8.0 at room
temperature for 2 h; or (d) with 92 µL water.
Samples (5 µL) were subjected to chromatographic separa-
tion on a 250 mm × 2.0 mm YMC ODS-AQ 5 µm C18 column
(Waters, Milford, MA) and eluted conjugates were analyzed with
a Thermo LCQ DecaXP ion trap mass spectrometer (Thermo-
Electron, San Jose, CA). The mobile phase consisted of 5%
acetonitrile, 95% water, and 0.1% formic acid (solvent A) and
95% acetonitrile, 5% water, and 0.1% formic acid (solvent B).
The ﬂow rate was 400 µL min-1, and the gradient program was
100% solvent A from 0 to 5 min, 100 to 40% A by 20 min, 40 to
0% A by 22 min, then held at 0% A from 22 to 25 min, followed
by a linear gradient to 100% A at 29 min, then held at 100% A
from 29 to 34 min.
Preparation of Yeast and Human Cell Tryptic Digests. A
human colon adenocarcinoma cell line (RKO) was obtained
from ATCC (Manassas, VA) and cultured in 175 mL cell culture
ﬂasks in McCoy’s 5A media (Mediatech, Herndon, VA) supple-
mented with 10% fetal bovine serum (Altas Biologicals, Fort
Collins, CO) at 37 °Ci n5 %C O 2. RKO cells were grown to
approximately 90% conﬂuence, then harvested in 5 mL of 0.25%
trypsin-EDTA, washed with PBS. A yeast protein extract was
prepared at the National Institute of Standards and Technology
for studies by the National Cancer Institute Clinical Proteomic
Technology Assessment for Cancer (CPTAC) network, as de-
scribed previously.
27 Solubilization and tryptic digestion of
proteins in the yeast and RKO cells was done by a modiﬁcation
of the method of Wang et al.
5 as we have described previously.
28
The method employed triﬂuoroethanol to solubilize cell and
tissue proteins prior to tryptic digestion. For the present study,
the only modiﬁcation to the described method was that
proteins were not treated with iodoacetamide following reduc-
tion with dithiothreitol and before the digestion step. After
digestion, the peptides were eluted from solid phase extraction
columns in acetonitrile/water (4:1, v/v) and the solutions were
evaporated to dryness in vacuo.
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prewashed three times with 50 mM sodium acetate buffer, pH
4.5 and then diluted with this buffer to achieve a 50:50 (v/v)
bead/buffer slurry. Tryptic peptides corresponding to 1.5 mg
yeast or RKO cell protein were redissolved in 100 µLo f1 0 0
mM sodium phosphate buffer, pH 7.0. After reducing with 10
mM dithiothreitol for 5 min, the sample was treated with 50
µL IBB (200 mM in TFE) in the dark at room temperature for
20 min to label cysteinyl peptides. The mixture was then added
to 15 mL streptavidin sepharose bead/buffer slurry and incu-
bated for 30 min in the dark at room temperature with gentle
mixing. The beads were then washed sequentially with 50 mM
sodium acetate buffer, pH 4.5 (2 × 7.5 mL), 50 mM sodium
acetate buffer, pH 4.5 containing 2 M NaCl (7.5 mL), and 50
mM ammonium bicarbonate, pH 8.0 (2 × 7.5 mL, quick). To
release carboxymethyl-cysteine containing peptides, the beads
were extracted twice (5 h and overnight) with 7.5 mL of 50 mM
ammonium bicarbonate, pH 8, at room temperature with
gentle mixing. The combined extract was lyophilized, resus-
pended in 1 mL of deionized water, desalted on a SEP-Pak vac
1 cc (100 mg) C-18 cartridge (Waters Corp., Milford, MA) and
then evaporated to dryness in vacuo.
IEF Fractionation of Peptides. Tryptic peptides (100 µg)
were resuspended in 500 µL of 6 M urea and loaded in an
IPGphor rehydration tray (GE Healthcare, Piscataway, NJ).
Immobilized pH gradient strips (24 cm, pH 3.5-4.5) were
placed over the samples and allowed to rehydrate overnight at
ambient temperature. The loaded strips were focused at 21 °C
on an Ettan IPGPhor-3 IEF system (GE Healthcare, Piscataway,
NJ) using an initial step at 300 V for 900 Vh, then gradient to
1000 V for 3900 Vh, then gradient to 8000 V for 13500 Vh, then
step to 8000 V for 93700 Vh. The strips were then cut into 10
(2.4 cm) pieces and placed in separate wells of a 96-well Falcon
ﬂat bottom polystyrene enzyme-linked immunosorbent assay
plate. Peptides were eluted from the strips with 200 µL of 0.1%
formic acid (FA) for 15 min, followed by 200 µL of 50% ACN/
0.1% FA for 15 min, then 200 µL of 100% ACN/0.1% FA for 15
min. The combined solutions of extracted peptides were
evaporated in vacuo, then resuspended in 1 mL of 0.1%
triﬂuoroacetic acid and desalted over a 96-well C18 Oasis
hydrophilic-lipophilic balance plate (30 µm particle size, 10
mg packing) (Waters Corp., Milford, MA). The combined
peptide solutions were evaporated in vacuo, redissolved in 100
µL of 0.1% FA for LC-MS/MS analysis.
LC-MS/MS Analysis of Peptide Mixtures. Reverse phase LC
of peptide mixtures was done with an Eksigent nanoLC and
autosampler (Dublin, CA). Peptides were separated on a packed
capillary tip (Polymicro Technologies, 100 µm × 11 cm) with
Jupiter C18 resin (5 µm, 300 Å, Phenomenex) using an in-line
solid-phase extraction column (100 µm × 6 cm) packed with
the same C18 resin (using a frit generated with liquid silicate
Kasil 1
29) similar to that previously described.
30 LC was done
at ambient temperature at a ﬂow rate of 0.6 µL min-1 using
mobile phases of 0.1% (v/v) formic acid in water (solvent A)
and 0.1% (v/v) formic acid in acetonitrile (solvent B). A 95 min
gradient was performed with a 15 min washing period (100%
A for the ﬁrst 10 min followed by a gradient to 98% A at 15
min) to allow for solid-phase extraction and removal of any
residual salts. Following the wash period, the gradient was
increased to 25% B by 50 min, followed by an increase to 90%
B by 65 min and held for 9 min before returning to the initial
conditions. Peptides were analyzed using a Thermo LTQ-
Orbitrap hybrid mass spectrometer (Thermo Fisher, San Jose,
CA). A full scan obtained for eluting peptides in the range of
400-2000 amu was collected on the Orbitrap at a resolution
of 60 000, followed by ﬁve data-dependent MS/MS scans on
the LTQ with a minimum threshold of 1000 set to trigger the
MS/MS spectra. In data-dependent MS/MS experiments, dy-
namic exclusion of previously analyzed precursors was set at
60 s with repeat of 1 and a repeat duration of 1. Centroided
MS/MS spectra were recorded on the LTQ-Orbitrap using an
isolation width of 2 m/z, an activation time of 30 ms, an
activation q of 0.250 and 30% normalized collision energy using
1 microscan with a max ion time of 100 ms for each MS/MS
scan and 1 microscan with a max ion time of 500 ms for each
full MS scan.
Data Analysis. Tandem mass spectra stored as centroided
peak lists from mass spectra .RAW ﬁles were read and transcod-
ed to mzData v1.05 ﬁles with the in-house developed “Scan-
Sifter” software. Only MS/MS scans were written to the mzData
ﬁles; MS scans were excluded. If 90% of the intensity of a
tandem mass spectrum appeared at a lower m/z than that of
the precursor ion, a single precursor charge was assumed;
otherwise, the spectrum was processed under both double and
triple precursor charge assumptions. Tandem mass spectra
were assigned to peptides from the IPI Human database version
3.37 (69249 sequences) for RKO or the Saccharomyces Genome
database (SGD, 6839 sequences) for yeast by the MyriMatch
algorithm, version 1.2.11.
31 The sequence database was doubled
to contain each sequence in both normal and reversed orienta-
tions, enabling false discovery rate estimation. MyriMatch was
conﬁgured to expect all cysteines to bear carboxymethyl
modiﬁcations (+58.00548 Da) and to allow for the possibility
of oxidation on methionines (+15.99492 Da) and cyclization
of N-terminal glutamine (-17.02655 Da). Candidate peptides
were required to have tryptic cleavages or protein termini at
both ends, though any number of missed cleavages was
permitted. A precursor error was allowed range up to 0.1 m/z
in either direction, but fragment ions were required to match
within 0.5 m/z. The IDPicker algorithm v2.1
32 ﬁltered the
identiﬁcations for each LC-MS/MS run to include the largest
set for which a 1% identiﬁcation false discovery rate could be
maintained. Because many identiﬁcations were done from
captured Cys-peptides, only one peptide sequence that met the
above criteria was required to identify a protein. Indistinguish-
able proteins were recognized and grouped, and parsimony
rules were applied to generate a minimal list of proteins that
explained all of the peptides that passed our entry criteria. False
discovery rates (FDR) were computed by the formula: FDR )
(2 × reverse)/(forward + reverse).
33 The algorithm reported the
number of spectra and number of distinct sequences observed
for each protein and protein group in each sample set.
Statistical Analysis. Log2-transformed spectral count ratios
were compared using a Kruskal-Wallis one-way ANOVA test
for multiple comparisons and 95% conﬁdence intervals were
determined.
Results
Synthesis of IBB and its Reaction with a Model Thiol
Peptide. We set out to prepare a thiol-reactive biotinylating
reagent containing a benzoin ester, as these structures are liable
to photodissociation.
26,34,35 The synthesis of IBB (Scheme 1)
was based on the preparation of methyl ester 4,
36 followed by
aminolysis to form 5 and subsequent biotinylation to give 6.
Subsequent 1,3-dithian deprotection to form 7 was followed
by iodoacetylation with iodoacetic acid to afford IBB (8), which
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benzoin group and biotin (Scheme 2A).
We ﬁrst studied the capture and release reactions of IBB
using the model Cys-containing peptide Ac-TpepC (Scheme
2B). Reaction of Ac-TpepC (0.25 mM) and DTT (5 mM) with
IBB (50 mM) in 100 mM sodium phosphate, pH 7.0 buffer
containing 33.3% TFE completely converted the peptide (peak
I) to the Ac-TpepC-IBB conjugate (peak II) after 20 min at room
temperature (Figure 1B). LC-MS analyses of Ac-TpepC-IBB
indicated that the conjugate was stable at pH 4.5, but increas-
ingly unstable at higher pH, yielding the hydrolysis product
S-carboxymethyl-Ac-TpepC (peak V), as indicated in Figure
2C-F. However, the Ac-TpepC-IBB conjugate was very stable
in 50 mM sodium acetate, pH 4.5 for up to 16 h at room
temperature (Figure 2G). Although the plotted data are from
total ion chromatograms, MS/MS analyses conﬁrmed the
structures of Ac-TpepC (Figure S1, Supporting Information),
its IBB conjugate (Figure S2, Supporting Information) and the
hydrolysis product S-carboxymethyl-Ac-TpepC (Ac-TpepC-IAA,
Figure S3, Supporting Information). The sensitivity of the thiol-
IBB conjugate to hydrolysis in mild base is consistent with the
properties of similar benzoin esters.
37
Cys-Peptide Enrichment. Our approach to evaluating cap-
ture and release of Cys-peptides in complex mixtures is
illustrated in Scheme 2C. Treatment of a tryptic peptide digest
with IBB/TFE at pH 7.0 results in alkylation of Cys-peptides to
form the biotin-tagged Cys-peptide conjugates, which are
applied to a streptavidin sepharose column at pH 4.5. The ﬂow
through (FT) fraction includes non-Cys-peptides, which are not
biotinylated. Nonbiotinylated peptides that nonspeciﬁcally bind
to the column are removed by washing with pH 4.5 sodium
acetate buffer and by additional washes with 2 M NaCl. The
captured Cys-peptides are then eluted (E) by hydrolysis with
ammonium bicarbonate. A global peptide mixture (G) is
generated as a reference for Cys-peptide enrichment by
incubating the IBB-treated peptide mixture at pH 8 before
applying to the streptavidin column. Neither the Cys-peptides
nor the non-Cys-peptides are retained on the streptavidin
column; this control corrects for any nonspeciﬁc effects of the
IBB labeling step or irreversible, nonspeciﬁc peptide binding
to the streptavidin column.
For each experiment, RKO cells or yeast lysates were
subjected to denaturation, reduction, and tryptic digestion. Two
aliquots of each sample then were alkylated with IBB. One IBB-
labeled aliquot was applied to a streptavidin column to
generate the FT and E fractions described above, whereas the
other was ﬁrst hydrolyzed with ammonium bicarbonate before
applying to the streptavidin column. The ﬂow-through from
this sample is the G fraction, which serves as a reference for
evaluating enrichment of Cys-peptides. Equal amounts of
peptides from the FT and E fractions from the ﬁrst sample and
from the G fraction from the second sample were then
analyzed.
In a preliminary test of the speciﬁcity and reproducibility of
this IBB Cys-peptide enrichment method, three replicate
samples of FT, E and G fractions prepared from yeast and from
RKO cell lysates were analyzed by reverse phase LC-MS/MS
(no IEF). For the replicate E fractions from RKO cells, the three
Scheme 1. Synthesis of IBB
a
a See “Experimental Procedures” for detailed description. Reagents: (a) TBDMSCl, Et3N, THF, 86%; (b) 2-phenyl-1,3-dithiane,
n-butyllithium, THF, 91%; (c) methyl bromoacetate, TBAF, THF, 93%; (d) 2,2′-(Ethylenedioxy)bisethylamine, MeOH, 75%; (e) biotin, CDI,
DMF, 56%; (f) HgClO4,C H 3CN/H2O, 69%; (g) iodoacetic acid, DCC, DMAP, 81%.
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which 91% were sequences containing at least one Cys residue
(Table 1). Individual values for the three replicates were 1367
identiﬁcations (92% Cys-peptides), 1428 identiﬁcations (93%
Cys-peptides and 1432 identiﬁcations (91% Cys-peptides).
Analysis of the FT fractions yielded similarly consistent data
across the three replicates, with 3,664 conﬁdent peptide
identiﬁcations, of which 98.6% were non-Cys-peptides. The
average percentage of identiﬁed Cys-peptides in the G fractions
was 6.7%. Analyses of the yeast fraction yielded similar results.
These data indicated that the IBB Cys-peptide enrichment
method displayed high speciﬁcity, efﬁciency and repeatability.
Global Impact of Cys-Peptide Enrichment Using IBB in
Proteome Analyses of Yeast and RKO Cells. For studies of the
effect of IBB Cys-peptide enrichment, the E and G fractions
were resolved into 10 fractions by IEF prior to LC-MS/MS. A
narrow 3.5-4.5 pI range separation was chosen based on
previous studies showing that a majority of proteins are
represented by tryptic peptides in this range.
28,38,39 All 30 IEF
fractions then were analyzed by LC-MS/MS. Compared to the
reverse phase LC-MS/MS analyses, these multidimensional
analyses yielded a 5-fold increase peptide identiﬁcations in RKO
cells and a 3-4 fold increase in yeast (Table 1).
For global quantitative assessment of the impact of Cys-
peptide enrichment on protein detection, we used spectral
count data as a measure of protein abundance.
40-42 In addi-
tion, our choice of yeast as a model proteome for these studies
was based on the availability of abundance-level annotation
of most yeast proteins from the quantitative tandem afﬁnity
puriﬁcation tag (TAP tag) studies of Ghaemmaghami et al.
43
This characteristic of the yeast proteome was utilized in our
recent work as part of the CPTAC network, which demonstrated
a high correlation between spectral count data and yeast
protein copy number.
27
Protein cysteine content should be major determinant of the
impact of IBB Cys-peptide capture on global protein identiﬁca-
tions. We chose to benchmark our analyses on the ratio of
cysteinyl tryptic peptides to total tryptic peptides (Cys-peptide
fraction), which was calculated through in silico tryptic diges-
tion of the entries in the IPI and SGD proteome databases. The
digestion criteria used were: (i) allowable peptide length was
5-40 amino acids; (ii) K-X and R-X comprise the only cleavage
Scheme 2. (A) Chemical Structure of Base-Cleavable Cysteine-Reactive Probe (IBB),
a (B) Modiﬁcation of Model Peptide (Ac-TpepC)
by IBB and Hydrolysis of the Conjugate, and (C) Experimental Design for Evaluation of IBB Labeling and Streptavidin Capture of
Cys Peptides
b
a Consists of three functional elements: a thiol-reactive iodoacetamido group, a mild base-cleavable benzoin linker and biotin afﬁnity
tag.
b FT denotes non-Cys-peptides not retained on streptavidin. E denotes S-carboxymethyl Cys-peptides released by hydrolysis of IBB.
G denotes complete mixture (“global fraction”) generated by hydrolysis of IBB-treated lysate before application to streptavidin. IBB labeling
of cysteinyl thiols is done at pH 7, whereas streptavidin capture is done at pH 4.5. Elution/hydrolysis of IBB Cys-peptide conjugates is done
at pH 8.
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ages at K-P and R-P sites were permitted (to simplify the
calculations).
In this study, protein enrichment or depletion is represented
by the log2-transformed ratio of spectral counts for proteins in
the Cys-peptide fraction (E fraction) to counts for the same
proteins in the global fraction (G fraction). This ratio, log2 (E/
G) is positive for proteins that are enriched in the E fraction
and is negative for proteins that are depleted in the E fraction.
Only proteins with at least two spectral counts combined from
triplicate analyses of the FT, E and G fractions from RKO cells
were considered. In yeast studies, only proteins with at least 3
spectral counts in the combined fractions were considered. This
restriction resulted in a protein level FDR of 0.034 (RKO cells)
and 0.045 (yeast). In cases where spectral counts in the E or G
fractions were zero, the value for that E or G fraction was
adjusted to “1” to ensure validity of log2(E/G).
The protein identiﬁcation data for yeast and RKO cell
proteins are plotted in Figure 2. Proteins are ordered on the
x-axis (“protein index”) in order of increasing fractional Cys-
peptide content (Cys-peptide fraction), which is shown on the
left y-axis of each plot. The red curves in Figure 2A and C
represent the theoretical Cys-peptide fraction (predicted Cys-
peptides/predicted tryptic peptides) for each protein, whereas
those in Figure 2B and D represent the detected Cys-peptide
fraction (detected Cys-peptides/detected tryptic peptides) for
each protein. The ﬂat segment of each red curve represents
proteins with no cysteine residues. The black data points
represent measured log2 (E/G) ratios for detected proteins (right
y-axis).
A total 3025 proteins from yeast were identiﬁed by triplicate
IEF-LC-MS/MS analyses using the identiﬁcation threshold
criteria described above. These proteins account for ∼44% of
the proteins in the SGD database. Of these, 345 proteins
generate no Cys-peptides upon in silico digestion and values
of log2 (E/G) for all of these were less than zero (Figure 2A).
The remaining 2736 proteins contained at least one Cys-
peptide. For these, a Spearman correlation (R ) 0.40) between
log2 (E/G) and Cys-peptide fraction suggested a modest en-
hancement of detection of proteins with higher Cys-peptide
fraction through the use of IBB capture. Similar results were
found in RKO cells, as shown in Figure 2B. A total 4887 proteins
were identiﬁed in triplicate analyses at the indicated threshold,
representing ∼7% of the proteins in the IPI database. Of the
identiﬁed proteins, 237 proteins yielded no cysteinyl peptide
upon in silico digestion. Almost all of these were not enriched
by IBB capture, as indicated by log2 (E/G) values less than zero.
The Spearman correlation (R ) 0.44) for the relationship
between log2 (E/G) and Cys-peptide fraction again indicated a
modest enrichment of proteins containing more Cys-peptides
by IBB capture.
We further analyzed the correlation between log2 (E/G) and
the ratio of detected Cys-peptides to detected total peptides
(detected Cys-peptide fraction) for each protein. Only seven
of 1131 proteins without Cys-peptides were found to be
enriched (Figure 2C), which provides an estimate of detectable
nonspeciﬁc binding to steptavidin. The correlation of log2(E/
G) with the detected Cys-peptide fraction (Spearman R ) 0.85)
was much stronger than for the relationship based on theoreti-
cal Cys-peptides. Figure 2D showed the similar results for RKO
cells, with a Spearman r ) 0.83 for the correlation of log2(E/G)
with the detected Cys-peptide fraction. Only 14 of 1569 RKO
proteins without Cys-peptides were enriched.
An important question is the degree to which Cys-peptide
enrichment expands the number of protein identiﬁcations.
Figure 3 provides a Venn diagrammatic representation of the
identiﬁcation overlaps between the E and G fractions for both
yeast and RKO cell analyses by IEF-LC-MS/MS. Although there
is considerable overlap in identiﬁcations between the G and E
fractions, the E fraction contained 287 unique identiﬁcations
for yeast and 569 unique identiﬁcations for RKO cells. Thus,
the content of the E fraction expanded identiﬁcations by 10.6%
for yeast and 13.0% in RKO cells.
Despite the chemical speciﬁcity of the IBB reagent for thiols,
enrichment of Cys-proteins in the above analyses could also
be due in part to a “fractionation effect”, in which the
separation of the peptide mixtures into subfractions (i.e., E and
FT fractions) yields more identiﬁcations by presenting simpler
mixtures for analysis. To further evaluate the contributions of
Figure 1. Reverse phase LC-MS total ion chromatograms for
reaction products of Ac-TpepC and IBB under different conditions.
The labeled peaks are I, Ac-TpepC; II, Ac-TpepC-IBB conjugate;
III, IBB hydrolysis product; IV, IBB; V, S-carboxymethyl-Ac-TpepC.
(A) Ac-TpepC; (B) Ac-TpepC-IBB conjugate formed by reaction
of Ac-TpepC with IBB in 100 mM sodium phosphate, pH 7.0,
containing 33.3% TFE at room temperature in dark for 20 min;
(C) Ac-TpepC-IBB conjugate in 50 mM sodium phosphate buffer
containing 3.67% TFE, pH 5.5 at 37 °C for 4 h; (D) Ac-TpepC-IBB
conjugate in 50 mM sodium phosphate buffer containing 3.67%
TFE, pH 6.5 at 37 °C for 4 h; (E) Ac-TpepC-IBB conjugate in 50
mM sodium phosphate buffer containing 3.67% TFE, pH 7.5 at
37 °C for 4 h; (F) Ac-TpepC-IBB conjugate pH 8.0, 50 mM
ammonium bicarbonate at room temperature for 5 h; (G) Ac-
TpepC-IBB conjugate in pH 4.5, 50 mM acetate buffer at room
temperature in the dark overnight.
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we did two additional analyses.
First, we asked whether enrichment tracked with detection
of methionine-containing peptides (Met-peptides). In silico
tryptic digestion of the SGD and IPI databases using the rules
outlined above yielded theoretical percentages of 23.3 and
23.9% Met-peptides for yeast and RKO, respectively, which were
similar to the percentages for Cys-peptides (15.5% in yeast and
23.9% in RKO cells) (Figure S4, Supporting Information).
Nevertheless, Figure S5A and B (Supporting Information)
showed that there was no signiﬁcant correlation between the
detected Met-peptide fraction and log2 (E/G) in either yeast or
Figure 3. Venn diagram representation of proteins uniquely
identiﬁed in yeast and RKO cells by Cys-peptide capture. Proteins
identiﬁed in global (G) and eluted (E) fractions are shown. Note
that 287 and 569 proteins were identiﬁed only in the E fractions
and thus indicate the beneﬁt of Cys-peptide capture.
Figure 2. Relationship between IBB enrichment effect and Cys-peptide abundance for detected proteins. Proteins are ordered on the
x-axis (“protein index”) in order of increasing fractional Cys-peptide content (Cys-peptide fraction), which is shown on the right y-axis
of each plot. The red curves in (A) and (C) represent the theoretical Cys-peptide fraction (predicted Cys-peptides/predicted tryptic peptides)
for each protein, whereas those in (B) and (D) represent the detected Cys-peptide fraction (detected Cys-peptides/detected tryptic peptides)
for each protein. The black data points represent log2-transformed ratios of spectral counts for detected proteins in the eluted (E)
fraction to the global (G) fraction and are plotted as log2 (E/G) (left y-axis). The listed R values are Spearman correlation coefﬁcients
for proteins with at least one predicted or detected Cys-peptide.
Table 1. Summary of Identiﬁed Yeast and RKO Cys-Peptides, Total Peptides and Proteins
LC-MS/MS IEF-LC-MS/MS
total Cys-peptides total peptides Cys-peptide % total proteins Cys-peptides total peptides Cys-peptides % total proteins
RKO G 233 3470 6.7 932 2786 18121 15.4 4390
E 1757 1932 91 915 7482 9081 82 3571
FT 5 3664 1.4 988 569 18986 3.0 4455
yeast G 181 4122 4.4 685 1165 12939 8.3 2705
E 1669 2014 83 810 4565 6052 75 2057
FT 9 4086 0.22 683 191 15554 1.2 2791
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approximates that of Cys-peptides in the database.
Next, we directly evaluated the fractionation effect. Our
triplicate IEF-LC-MS/MS analyses of yeast peptides (100 µg)
from the G fractions yielded 58094 conﬁdently identiﬁed
spectra, whereas only 20443 were found in the E fraction
(Figure 2). This suggested an apparently lower complexity of
the E fraction relative to the G fraction. Analysis of the lower
complexity E fraction could yield identiﬁcations not seen in
the more complex G mixture. To model the fractionation effect,
we reanalyzed both the entire G fraction and also selected IEF
fractions 4, 5 and 6, which together yielded 19 042 identiﬁed
spectrasthis is close to the total of 20 443 conﬁdently identiﬁed
spectra found in the E fraction. If a fractionation effect
contributed to enrichment, we would ﬁnd a signiﬁcant number
of proteins with higher spectral counts in the sample assembled
from the IEF 4, 5, and 6 subfractions than in the entire G
fraction. However, analysis of the data (Figure 4A) indicated
that only 9 yeast proteins were found to be slightly enriched
(i.e., positive log2 (G4,5,7/G) values). This is in contrast to the
much more dramatic effect of IBB captures842 cysteine-
containing proteins were found to be enriched in the IBB-
selected E fraction, which represented the same number of
spectra (see Figure 2B). We repeated this experiment in yeast
by selecting either IEF fractions 3, 8, and 9 or fractions 1, 2, 7,
and 10 from the G fraction, whose summed spectral counts
were 18 360 and 20 548, respectively, were also close to the
20 443 spectra represented by the IBB-captured E fraction.
Again, these selected subsets of the G fraction showed no
enrichment as a result of IBB capture (data not shown). The
same analysis with the RKO proteome selected fractions 4, 5,
6, and 7 from the global sample identiﬁed 24 563 spectra, which
is close to the 22 828 spectra found in the E fraction from RKO
cells following IBB capture. No enrichment of peptides in the
selected fraction was detected as a result of IBB capture (Figure
4B). These data conﬁrm that the enrichment detected as a
result of IBB capture was due to the chemoselective enrichment
of Cys-peptides in the E fraction, rather than to a simple
fractionation effect that reduced the complexity of the E
fraction.
Impact of Chemoselective Cys-Peptide Capture on
Detection of Low Abundance Proteins. Gygi et al.
4 demon-
strated that Cys-peptide enrichment with an ICAT reagent
combined with strong cation exchange fractionation of peptides
and LC-MS/MS expanded coverage of the yeast proteome. The
combination of ICAT and multidimensional LC-MS/MS ap-
proach increased the detection of lower abundance yeast
proteins, as estimated by codon bias values, which provide an
indirect measure of abundance.
44,45 Since that work, a major
advance in the ﬁeld was the publication of direct measurements
of yeast protein abundance by a quantitative TAP tag ap-
proach.
43
Of the 3025 yeast proteins we detected, 2088 (69%) were
annotated for expression level in the yeast TAP tag data set.
These proteins were allocated into bins based on TAP tag copy
number and the log2 (E/G) values were plotted (Figure 5). The
mean log2 (E/G) value for each bin was inversely proportional
to expression copy number. ANOVA analyses indicated signiﬁ-
cant differences between log2 (E/G) values for proteins at
different abundance levels (p < 0.001). Only 1 (1.3%) protein
was enriched in the highest copy number (>105) group, whereas
181 (40%) were enriched in the lowest abundance level group
(<102).
As noted above, this analysis demonstrates that Cys-peptide
enrichment is greatest for lower abundance proteins, but does
not indicate the degree to which enrichment increases the
identiﬁcation of lower abundance proteins. Figure 6 provides
a Venn diagrammatic representation of the identiﬁcation
overlaps between the E and G fractions for yeast proteins as a
function of abundance. The E fraction contained no unique
identiﬁcations at the highest abundance level (>105 copies/cell).
However, at lower copy numbers, the numbers of unique
identiﬁcations in the E fraction expanded dramatically. In the
intermediate copy number bins (104-105 copies/cell and
103-104 copies/cell), the E fraction accounted for 1.6 and 9.9%
of the identiﬁcations, respectively. At the lowest copy number
level (0-103 copies/cell), the E fraction accounted for 86.4% of
the identiﬁcations.
Spectral count data provide a measure of relative protein
abundance
40-42 and have been shown to correlate with TAP
tag copy number in yeast
27 and we observed the same
correlation in our data set for the yeast G fraction (Figure S6,
Supporting Information). Accordingly, we allocated the identi-
ﬁed yeast proteins into bins based on protein spectral counts
(Figure 7). As in the analysis based on TAP tag copy numbers,
the mean log2 (E/G) for each spectral count bin was inversely
proportional to protein abundance. Only 16/594 proteins (2.7%)
in the highest spectral count bin were enriched by IBB capture,
Figure 4. Relationship between fractionation effect and Cys-peptide abundance in (A) yeast and (B) RKO cell proteins. Layout of plots
is as for Figure 2, except that IEF subfractions 4, 5, and 6 (A) or IEF subfractions 4, 5, 6, and 7 (B) were substituted for the E fraction
in IBB fractionated samples.
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count bin were enriched. One way ANOVA of log2 (E/G) values
indicated signiﬁcant differences in enrichment between each
group (p < 0.001).
Application of the same analysis to the RKO data set yielded
similar results (Figure 8). The degree of enrichment by IBB
capture was inversely proportional to protein abundance level.
All groups were signiﬁcantly different (p < 0.001) except the
highest and second highest abundance levels (Figure 8). We
found that only 25/923 (2.7%) of the proteins in the highest
spectral count bin were enriched, whereas 666/1047 (64%) of
the proteins in the lowest spectral count bin were enriched.
These data demonstrate that chemoselective Cys-peptide
fractionation with IBB provides a selective enrichment of low
abundance proteins in both yeast and in RKO cells.
We consistently observed that Cys-peptide enrichment was
most effective for low abundance proteins. This raised the
possibility that cysteine content was proportionately higher in
low abundance proteins. We addressed this possibility by
calculating the theoretical Cys-peptide fraction (Cys-peptides/
tryptic peptides) for the TAP tag copy number annotated
proteins reported by Ghememaghami et al.
43 (Figure S7,
Supporting Information). We found no relationship between
protein copy number and theoretical Cys-peptide fraction.
Classiﬁcation Analysis of RKO Cell Proteins Identiﬁed
by Cys-Peptide Enrichment with IBB. We asked whether
chemoselective fractionation with IBB exhibits selectivity for
proteins based on subcellular distribution or functional clas-
siﬁcation. We compared the distributions based on cellular
component (Figure S8, Supporting Information), biological
process (Figure S9, Supporting Information) and molecular
function (Figure S10, Supporting Information) for identiﬁed
proteins in the G and E fractions in RKO cells using the
WebGestalt gene annotation tool, which allows facile compari-
son for large protein data sets.
46 The IPI protein accession
numbers generated by our analyses were converted to Entrez
gene accession numbers, resulting in 4709 (96.3%) proteins
represented in this analysis out of 4887 proteins in the primary
data set. We note that a protein could be categorized in
different locations, biological process or molecular function.
For example, 41 proteins were found in both the nucleus (1482
proteins) and mitochondrion (465 proteins). No signiﬁcant
differences were noted in the distributions of proteins identiﬁed
from the E fraction and the G fraction based on cellular
location, biological process or molecular function. This sug-
gested that chemoselective fractionation with IBB exhibits no
bias for proteome components.
Discussion
Our objective in these studies was to assess the impact of
Cys-peptide capture for global proteome analyses. We em-
ployed a novel biotinylating reagent for Cys-peptides that is
cleavable under mildly basic conditions and is easily integrated
Figure 5. Impact of chemoselective fractionation with IBB on detection of yeast proteins annotated with TAP tag copy numbers. Proteins
are grouped by copy number into four bins on the x-axis. One-way ANOVA analyses indicate signiﬁcant differences in IBB enrichment
effect based on protein spectral counts in global (G) fraction. Data points represent log2 (E/G) for detected protein spectral counts in
the eluted (E) fraction to the global (G) fraction. Means for each group are indicated by a long black line, and standard error of the
mean (SEM) are indicated by short lines. *** Indicates p < 0.001.
Figure 6. Venn diagrammatic representation of enhanced iden-
tiﬁcation of low abundance, Cys-containing proteins in yeast. The
number of identiﬁcations from the Cys-peptide-containing eluted
(E) fraction is inversely proportional to protein copy number.
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has been studied previously with other reagents and we
anticipate that our results broadly reﬂect the impact of thiol-
directed capture chemistries. A key element of our study is the
Figure 7. Impact of chemoselective fractionation with IBB on detection of yeast proteins grouped by spectral counts. Proteins are
grouped by spectral counts into ﬁve bins on the x-axis. One-way ANOVA analyses indicate signiﬁcant differences in IBB enrichment
effect based on protein spectral counts in global (G) fraction. Data points represent log2 (E/G) for detected protein spectral counts in
the eluted (E) fraction to the global (G) fraction. Means for each group are indicated by a long black line, and standard error of the
mean (SEM) are indicated by short lines. *** Indicates p < 0.001.
Figure 8. Impact of chemoselective fractionation with IBB on detection of RKO proteins grouped by spectral counts. Proteins are grouped
by spectral counts into ﬁve bins on the x-axis. One-way ANOVA analyses indicate signiﬁcant differences in IBB enrichment effect
based on protein spectral counts in global (G) fraction. Data points represent log2 (E/G) for detected protein spectral counts in the
eluted (E) fraction to the global (G) fraction. Means for each group are indicated by a long black line, and standard error of the mean
(SEM) are indicated by short lines. *** Indicates p < 0.001.
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notated for cellular expression levels
43 and provides benchmark
reference for comparison with spectral count data from LC-MS/
MS analyses.
27 This provided a means of validating the spectral
counting approach to quantify global enrichment of Cys-
peptides in both yeast and human RKO cell proteomes. Our
results demonstrate not only that Cys-peptide capture broadly
enhances detection of Cys-proteins and expands the entire
proteome inventory but that the effect is most pronounced for
lower abundance Cys-proteins.
The rationale for Cys-peptide capture is to simplify the
analysis by selecting a smaller set of peptides that represent
the larger collection. IBB-based fractionation generates a nearly
pure collection of Cys-peptides and this enrichment step
enhances detection of Cys-proteins in direct proportion to their
cysteine content. The degree of enrichment was most typically
2-8-fold but ranged up to almost 20-fold for a few proteins.
Identiﬁcations made in the Cys-peptide fraction can be added
to the global inventory to expand overall proteome coverage.
This is essentially the approach used by Liu et al.
3 and Wang
et al.,
5 who used thiopropyl Sepharose for Cys-peptide enrich-
ment. Our work extends their ﬁndings by quantitatively docu-
menting the enhanced detection of low abundance proteins
in yeast and extending this quantitative evaluation to a human
cell proteome.
Our results raise the question of why Cys-peptide enrichment
has the greatest effect on detection of low abundance proteins
with higher cysteine content. We considered the possibility that
lower abundance proteins may have greater fractional cysteine
content, but an in silico analysis of TAP tag data from the yeast
proteome indicates no such relationship (Figure S7, Supporting
Information). It seems likely that the elimination of non-Cys-
peptides in the E fraction generates a mixture in which Cys-
peptides from lower abundance proteins compete with fewer
high abundance peptides for detection in the MS instrument.
Proteins with greater numbers of cysteines have a greater
probability of being detected, due to their representation by
more Cys-peptides. Moreover, it appears that peptides in the
E fraction map to a more diverse set of proteins. Inspection of
Table 1 indicates that the E fractions invariably yield fewer
peptide identiﬁcations than do the G fractions, yet both
fractions yield comparable numbers of protein identiﬁcations.
This observation also suggested to us the alternate possibility
that enhanced detection of low abundance proteins was due
to a fractionation effect. In this scenario, the E fraction yields
additional identiﬁcations not because it is enriched in Cys-
peptides, but simply because it represents a simpler subfraction
of the global mixture. To test this hypothesis, we combined
IEF subfractions from the global mixture (G fraction) to
approximate the numbers of conﬁdent peptide identiﬁcations
in the E fraction. However, these combined IEF subfractions
failed to generate the enhanced detection of their components.
In contrast, analysis of the Cys-peptide-rich E fraction signiﬁ-
cantly expanded the list of identiﬁcations. This experiment
clearly demonstrated that the advantage of chemoselective
fractionation lies in the chemoselection per se, rather than in
the fractionation effect. Chemoselective fractionation thus
yields a subset of peptides that is broadly representative of the
entire proteome. Physical fractionation (e.g., IEF) yields subsets
of peptides in any fraction that have similar properties, but
that may be much less representative of the overall composition
of the proteome.
Our results indicate that chemoselective fractionation based
on Cys-peptide capture can enhance global proteome coverage,
especially for low abundance proteins that contain cysteines.
Incorporation of a chemoselective fractionation step into
proteome analysis workﬂows can signiﬁcantly expand the
coverage of proteomes. Although we have characterized Cys-
peptide capture in the context of data-dependent LC-MS/MS
analyses on ion trap instruments, the rapid emergence of
targeted proteomics using multiple reaction monitoring MS
suggests a possible role for chemoselective fractionation in the
development of sensitive and speciﬁc targeted quantitative
analysis strategies. IBB or similar reagents could be used in
this context to enhance targeted analysis of low abundance,
cysteine-rich proteins.
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